TY - JOUR
T1 - Increasing uptake of comparative effectiveness and patient-centered outcomes research among stakeholders
T2 - Insights from conference discussion
AU - Law, Ernest
AU - Harrington, Rachel
AU - Alexander, G. Caleb
AU - Saha, Soumi
AU - Oehrlein, Elisabeth
AU - Perfetto, Eleanor M.
N1 - Funding Information:
GC Alexander is Chair of the FDA’s Peripheral and Central Nervous System Advisory Committee; serves as a paid consultant to Quintiles and IMS; and is a member of OptumRx’s P&T Committee. This arrangement has been reviewed and approved by Johns Hopkins University in accordance with its conflict of interest policies. E Law was supported by the UIC/Takeda Health Economics and Outcomes Research Fellowship (2014–2016). E Oehrlein is supported by a PhRMA Foundation Fellowship in Health Outcomes. She also receives research support from Pfizer. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed. No writing assistance was utilized in the production of this manuscript.
Publisher Copyright:
© 2018 2018 Ernest Law.
PY - 2018/2
Y1 - 2018/2
N2 - The goal of comparative effectiveness research (CER) and patient-centered outcomes research (PCOR) is to improve health outcomes by providing stakeholders with evidence directly relevant to decision making. In January 2017, the Pharmaceutical Research and Manufacturers Association Foundation, alongside the Academy for Managed Care Pharmacy, organized a conference aimed at engaging experts and opinion leaders representing clinicians, patients and payers to identify and discuss barriers and strategies to enhancing uptake and use of CER/PCOR. This report summarizes the conference discussion in the following sections: preconference survey; summary of barriers and strategies to the uptake of CER/PCOR identified by conference attendees; and future perspectives on the field.
AB - The goal of comparative effectiveness research (CER) and patient-centered outcomes research (PCOR) is to improve health outcomes by providing stakeholders with evidence directly relevant to decision making. In January 2017, the Pharmaceutical Research and Manufacturers Association Foundation, alongside the Academy for Managed Care Pharmacy, organized a conference aimed at engaging experts and opinion leaders representing clinicians, patients and payers to identify and discuss barriers and strategies to enhancing uptake and use of CER/PCOR. This report summarizes the conference discussion in the following sections: preconference survey; summary of barriers and strategies to the uptake of CER/PCOR identified by conference attendees; and future perspectives on the field.
KW - comparative effectiveness
KW - patient-centeredness
KW - stakeholder engagement
UR - http://www.scopus.com/inward/record.url?scp=85042697374&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85042697374&partnerID=8YFLogxK
U2 - 10.2217/cer-2017-0060
DO - 10.2217/cer-2017-0060
M3 - Article
C2 - 29465252
AN - SCOPUS:85042697374
SN - 2042-6305
VL - 7
SP - 181
EP - 191
JO - Journal of Comparative Effectiveness Research
JF - Journal of Comparative Effectiveness Research
IS - 2
ER -